The effect of the synthetic extracellular matrix (ECM) in a diffusion chamber for a bioartificial endocrine pancreas (Bio-AEP) on pancreatic endocrine cells in vitro and its biocompatibility in dogs were investigated. Two different types of ECM were used: type I collagen treated with low antigen (type I LA), and reconstituted basement membrane matrix (Matrigel) derived from Englbreth-Holm-Swarm (EHS) mouse sarcoma. Matrigel contains growth and differentiation factors and cell adhesion molecules such as laminin, heparan sulfate proteoglycan, and entactin. Purified porcine pancreatic endocrine (PE) cells were suspended in type I LA or Matrigel and then placed into a 12-well culture plate (4 × 10 7 cells/ml ؒ gel/well). The insulin accumulation from PE cells in Matrigel was significantly greater than that in type I LA (9.3 ± 3.6 mU/well vs. 2.3 ± 1.3 mU/well). When Bio-AEP with Matrigel and PE cells was implanted into the abdominal cavity of a pancreatectomized diabetic dog, the exogenous insulin requirement for maintaining normoglycemia was reduced for the first 4 weeks. However, after 6 weeks of implantation, fasting blood glucose levels suddenly increased. Laparotomy revealed encapsulated Bio-AEP with thick fibrous tissue. Following removal of the Bio-AEP from the abdominal cavity, another Bio-AEP containing type I LA and PE cells was implanted into the same dog. The exogenous insulin requirement was gradually decreased to almost half that of preimplantation levels. Bio-AEPs containing type I LA or Matrigel, but not PE cells, were implanted into the abdominal cavities of four healthy dogs. After 4 weeks of implantation, the Bio-AEP with Matrigel was encapsulated with fibrous tissue similar to that in the diabetic dog, but the Bio-AEP with type I LA was not. These results indicate that Matrigel may be incompatible with dogs and that the type I LA is more suitable for Bio-AEP.
INTRODUCTION
rodents, convincing proof of their long-term efficacy in larger animal models is lacking (17) . Key factors for a The transplantation of islet cells or the whole panbiohybrid pancreas to be successful may include the islet creas is considered only a curative therapy for patients cells surviving for a relatively long period, correctly rewith insulin-dependent diabetes mellitus. However, sponding to glucose stimulation, and being biocompatithere have been many problems that include the limited ble with the recipient. availability of donor organs and the requirement for gen-
We have studied islet cell transplantation using a diferalized immunosuppression. Another potentially curafusion chamber for bioartificial endocrine pancreas tive treatment is the implantation of bioartificial pancre-(Bio-AEP) containing porcine pancreatic endocrine (PE) atic devices containing xenogeneic islet cells isolated cells for the treatment of diabetic rats. The Bio-AEP is from the host immune system. During the last few decconstructed with a silicon ring (diameter 4 cm, 0.5 cm ades, many biohybrid devices have been described in thickness) and two nuclepore membranes (pore size (2,5,7,15,17,18). Although these devices have been suc-0.1 µm, 10 µm in thickness, polycarbonate; Nuclepore Co., California, USA), which isolate PE cells from the cessful in vitro and in experimentally induced diabetic 494 EDAMURA ET AL.
terhouse. These pancreases were immediately trimmed and minced with scissors. The minced pieces of pancreatic tissue were digested, and the PE cells were easily separated from the connective tissue fragments by gentle stirring. The PE cells were harvested by autodigestion without added enzymes. The isolated crude cells were purified by Histopaque-1077 (Sigma Co., St. Louis, MO, USA). The purified PE cells were then placed in culture flasks. On day 7 of culture, the medium was discarded and replaced with EDTA-trypsin (GIBCO, Life Technologies Oriental Inc., Grand Island, NY, USA). The cells were collected in RPMI medium and cultivated in the following synthetic ECM.
Synthetic Extracellular Matrix (ECM)
The synthetic ECM was composed of 1.0% agarose, 0.005% maltose-carrying poly-styrene, 10 mM nicotinamide, and ECM gel. In this experiment, two different types of ECM gels were used: type I LA (Cellmatrix LA; Nitta Gelatin Co., Osaka, Japan) treated with low antigen and derived from porcine skin, and Matrigel (ECM Gel; Sigma) derived from EHS mouse sarcoma. 4 × 10 7 cells/ml ؒ gel/well (n = 5 each). The ECM containing PE cell clusters was fed with RPMI-1640 containing 11 mM D-glucose and 10% heat-inactivated fetal host immune system. Within the chamber, PE cells are bovine serum and incubated for 7 days at 37°C in 5% suspended and cultured in collagen gel as a major com-CO 2 and humidified air. Insulin levels in the medium ponent of the synthetic ECM (3, [12] [13] [14] . over a 7-day period were measured by radioimmunoasIn our previous studies, type I LA was used as an say (RIA; AB Beads insulin "Eiken"; Eiken Chemical ECM in a Bio-AEP (3,13). It has recently been reported Co., Ltd., Tokyo, Japan). that laminin-1 in a collagen gel may promote growth
Insulin Secretion From PE Cells In Vitro

Implantation of a Bio-AEP Into a and differentiation of pancreatic beta-cells (4). Matrigel
Pancreatectomized Dog derived from Englbreth-Holm-Swarm (EHS) mouse sarcoma contains laminin-1, type IV collagen, proteogly-A Bio-AEP containing PE cells (2.8 × 10 8 cells; 1.4 can, and entactin, suggested to be superior to type I LA.
× 10 5 islets) with type I LA or Matrigel was implanted However, the effect of Matrigel on insulin secretion into the abdominal cavity of a pancreatectomized diafrom PE cells and its biocompatibility in dogs have not betic dog (9-month-old male Beagle dog). Before and been fully investigated.
after the implantation, exogenous insulin necessary to The purpose of this study was to evaluate the in vitro maintain normoglycemia was administered twice a day responsiveness of PE cells to glucose stimulation and to the dog. Fasting blood glucose (FBG) levels and the the in vivo biocompatibility of Bio-AEP with type I LA dose of exogenous insulin required were examined every or Matrigel as a component of the synthetic ECM.
day, and fructosamine was measured once a week during the experimental period.
MATERIALS AND METHODS
Implantation of Bio-AEPs Without PE Cells Into Preparation and Culture of Porcine Pancreatic Normal Dogs Endocrine Cells
The preparation and purification methods for adult In another study, Bio-AEPs containing type I LA (n = 2) or Matrigel (n = 2) but not PE cells were im-PE cells have been described elsewhere (8) (9) (10) (11) 16) . Briefly, pancreases were obtained from a local slaughplanted into the abdominal cavities of four healthy Bea-gle dogs. Four weeks after the implantation, gross findweeks after implantation and revealed fibrous tissue encapsulation around the Bio-AEP (Fig. 3a, b) . Following ings of the Bio-AEP were observed on laparoscopy.
removal, another Bio-AEP with type I LA and PE cells Statistical Analysis was implanted into the abdominal cavity of the same The Student's t-test was used for the statistical analydog. The FBG levels again gradually decreased, and the sis of the insulin values in the medium, and p values dose of exogenous insulin was reduced to half that of less than 0.05 were considered to be significant. preimplantation levels.
RESULTS
Implantation of Bio-AEPs Without PE Cells Into Normal Dogs Insulin Accumulation
Laparoscopic findings of Bio-AEPs with type I Figure 1 shows the insulin accumulation in the me-LA implanted into two dogs revealed no abnormalities dium. The amount of insulin secreted into the medium such as adhesion, abscess formation, and/or fibrous tisfrom PE cells in Matrigel was 9.3 ± 3.6 mU/well, while sue encapsulation (Fig. 4) . However, Bio-AEP with Mathat from the cells in type I LA was significantly lower trigel implanted into one dog could not be identified on (2.3 ± 1.3 mU/well). laparoscopy; therefore, laparotomy was performed. The Implantation of a Bio-AEP Into a chamber was encapsulated by dense fibrous tissue and Pancreatectomized Dog the nuclepore membrane was ruptured (Fig. 5a, b) . A Bio-AEP in another dog showed some discoloration on Figure 2 shows the changes in FBG levels, fructothe surface of the nuclepore membrane that could potensamine levels, and the dose of exogenous insulin. One tially lead to fibrous tissue encapsulation. week after implantation, the dose of exogenous insulin was gradually decreased. FBG and fructosamine levels DISCUSSION were maintained within the normal range for 4 weeks. However, 5 weeks later, the FBG levels suddenly in-
The results of this study indicated that the amount of insulin accumulation in the medium from PE cells in creased. Experimental laparotomy was performed at 7 cellular differentiation or the total number of PE cells in each well, it is thought that a larger number of or more active PE cells must have existed in the synthetic ECM when using Matrigel, with a higher amount of insulin being secreted.
The dog implanted with a Bio-AEP containing Matri- of preimplantation levels for a longer period. The Bio-AEP containing Matrigel was encapsulated by fibrous tissues, and a nuclepore membrane was ruptured, sugMatrigel was significantly higher than that in type I LA. The type I LA used in this study was refined and treated gesting an incompatibility of the Bio-AEP. In addition, the Bio-AEP containing Matrigel but no PE cells imwith low antigen. In contrast, Matrigel was neither refined nor treated and was expected to contain laminin-1 planted into normal dogs also showed a similar response, while no such responses were observed when as a major component. Jiang et al. have reported that laminin-1 promotes differentiation and proliferation of Bio-AEPs with type I LA were implanted into normal dogs. insulin-positive beta-cells and that its effects on betacell number are dose dependent (4). It is possible that
The precise etiology for the incompatibility of Bio-AEP with Matrigel is unknown, but one of the potential laminin or other minor factors such as heparan sulfate proteogycan and entactin may have influenced the islet causes for graft failure may be the influence of cell growth and differentiation factors and cell adhesion molcell microenvironment to proliferate and differentiate PE cells in this study. Although we did not investigate the ecules. These factors could diffuse from a Bio-AEP with Matrigel through the nuclepore membrane, as its pore As far as the results of this study are concerned, a Bio-AEP with type I LA used as the synthetic ECM size is sufficient for the factors to pass through. It has been reported that laminin in Matrigel could stimulate component was biocompatible in dogs, and its use was preferable to the Bio-AEP with Matrigel. Further refibroblast attachment and spreading (1), and heparan sulfate proteoglycan may be associated with basic fibrosearch is necessary to establish a suitable Bio-AEP with type I LA that can trap a large number of PE cells and blast growth factors (bFGFs) through its binding with heparan sulfate bFGF receptors (6) . Therefore, these sensitively respond to blood glucose levels. molecules in Matrigel may stimulate the fibrous tissue implanted without PE cells. Therefore, insulin should not be included in this response. In this study, type I LA REFERENCES used was refined and treated with low antigen, whereas
